UNSPSC 85814914: Introduction of other antineoplastic into male reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into male reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0N305

UNSPSC 85814914 Introduction of other antineoplastic into male reproductive, percutaneous approach is a Commodity code that does not reflect the activity captured in recent state and local opportunities tagged to it. The recent solicitations show no alignment with the code's clinical procedure scope and instead encompass diverse healthcare service procurements—virtual urgent care, medical services, PACE operations, cancer screening, occupational health, behavioral health, EMS revenue billing, and other delivery models that bear no connection to antineoplastic oncology interventions.

State and local governments posting under this code are purchasing primary care, urgent care, occupational health, specialty care management, behavioral health services, and administrative health support across counties, cities, health authorities, and state departments in California, Georgia, Nevada, Colorado, Texas, Kansas, Florida, Arizona, Oregon, New Jersey, and other jurisdictions. Representative recent opportunities include the Inland Empire Health Plan (California) requesting virtual urgent care via RFI with response due October 31, 2026; DeKalb County, Georgia soliciting medical services under annual contract with renewals, proposals due November 12, 2026; and the Nevada Health Authority requesting PACE operations proposals, due December 10, 2026. The code shows no recent relevant activity—the mismatch between the procedure-specific code name and the general healthcare service delivery opportunities suggests systematic miscoding or a data classification error rather than active procurement under the intended commodity scope.